Accessed through the Hayes Knowledge Center, the Evidence Analysis Solution addresses the following fundamental questions to help our clients determine coverage positions:
Focus of the Report: This report focuses on fecal calprotectin (FC) testing to monitor disease activity and guide therapy choices in patients who have ulcerative colitis (UC).
Technology Description: Calprotectin is a calcium-binding protein that is abundant in neutrophils. During acti…
Focus of the Report: This report focuses on fecal calprotectin (FC) testing for determining the prognosis of disease activity (i.e., predicting clinical relapse) in patients who are undergoing treatment for ulcerative colitis (UC).
Technology Description: Calprotectin is a calcium-bind…
Focus of the Report: This report focuses on the use of fecal microbiota transplantation (FMT) to treat adults with ulcerative colitis (UC).
Technology Description: FMT is a procedure by which processed stool from healthy donors is infused into a patient’s gastrointestinal (GI) system for the purpose of treating a disease associated with impaired gut mi…
Focus of the Report: The use of Zilretta (triamcinolone acetonide extended-release injectable suspension) for the treatment of pain associated with knee osteoarthritis (KOA).
Technology Description: Zilretta (Flexion Therapeutics Inc.) is an extended-release intra-articular therapy for pat…
Focus of the Report: This report focuses on the use of radiofrequency ablation (RFA) for treatment of symptomatic benign thyroid nodules (BTNs) in adult patients.
Technology Description: RFA is an ultrasound (US)-guided, minimally invasive treatment approach, which applies high frequen…
Focus of the Report: This report focuses on annular closure for the prevention of recurrent lumbar disc herniation (LDH) after lumbar discectomy (LD).
Technology Description: Annular closure is a surgical treatment that is performed immediately following an LDH debridement surgery (e.g., l…
Focus of the Report: This report focuses on the use of botulinum toxin (BTX) for treatment of pain associated with temporomandibular disorders.
Technology Description: BTX, a neurotoxin produced by the bacterium Clostridium (C.) botulinum, is classified into 8 …
Focus of the Report: This report focuses on acupuncture (AP) for treatment of allergic rhinitis.
Technology Description: Traditional AP employs thin metal needles to pierce the skin at specific, defined sites. Related treatments involve application of pressure, electrical stimulation (…
Focus of the Report: Substance abuse and drug addiction are conditions that are notoriously difficult to treat with long-term success, as 40% to 60% of patients with drug addiction relapse. Mobile medical applications (MMAs) may fill gaps that currently exist in conventional treatment programs by enabling patients to better manage their care and track their health and wellnes…
Focus of the Report: This report focuses on the use of peripheral nerve field stimulation (PNFS) to treat refractory chronic low back pain (CLBP).
Technology Description: Peripheral nerve field stimulation is a neuromodulation technology characterized by ease of implant with minimized …